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Objective. To investigate whether general practitioners (GPs) and patients agree on what 
constitutes the best evidence for the effectiveness of treatments. 
Method. GPs and members of the public aged 18-83 read five scenarios describing 
comparisons between hypothetical treatments for common ailments. Each scenario reported 
that one treatment was the more effective, as determined by randomised controlled trial 
(RCT), audit of treatment outcomes from many doctors’ patients, a single doctor’s clinical 
experience, a friend’s experience, or a web-based sales site. Participants rated how confident 
they would be that the treatment reported to be more effective would work for them. 
Results. All participants had least confidence in the web-based sales site, more confidence in 
a friend’s experience and more still in one doctor’s experience. For doctor’s experience, audit 
and RCT, amongst the public there were some differences by age but, importantly, only GPs 
had most confidence in evidence from an RCT.  
Conclusion. GPs may treat evidence from RCTs as the gold standard while members of the 
public (their patients) may not afford it that same respect. 
Practice Implications. GPs engaged in shared decision-making should be alert to possible 
differences from their patients in the weight given to different types of evidence. 
  




Do the Public Share Practitioners’ Views about the Best Evidence? 
1. Introduction 
 In clinical policy and practice in the UK and US, it is currently considered important 
that decisions about treatments should be (i) based on the best available evidence and (ii) 
shared between patient and practitioner. The research reported here examines the relationship 
between these two aspects of current best practice by asking the question: Do practitioners 
and members of the public share the same views about what constitutes reliable evidence? 
With advice and information about medical conditions widely available in the media, it may 
not be uncommon for patients to have formed views about their preferred treatment before 
they consult their doctor. Suppose patients place trust in sources of evidence that their doctors 
do not consider reliable. Shared decision-making is likely to be impeded, especially if the 
mismatch in degree of trust remains implicit during the consultation. As a first step in 
identifying the extent of any such problem, we asked general practitioners (primary care 
physicians) and members of the public (potential patients) to indicate their trust in five 
different sources of evidence concerning the effectiveness of hypothetical treatments for a 
variety of common ailments. The sources of evidence were: randomised controlled trial 
(RCT), retrospective study of outcomes of many doctors’ treatment decisions (audit), a single 
doctor’s clinical experience, a friend’s experience, and the recommendation from a web-
based sales company.  
 RCTs are considered by many clinicians, researchers, funding bodies and policy 
makers to represent the gold standard for evidence based medicine, although some have 
urged that other forms of evidence not be under-valued [1;2;3;4]. Evidence from 
retrospective studies of non-randomised allocation to treatments by a large number of 
practitioners (here we use the term audit), is widely considered to be less compelling than that 
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from RCTs, although some researchers dispute claims of bias [2;3;4]. Bias to a much greater 
extent can arise in the clinical experience of a single practitioner. Hence it is relatively 
uncontroversial to rank these three sources of evidence about the effectiveness of treatments 
in the order: (i) RCT, (ii) audit, and (iii) a single doctor’s experience. Even less controversial 
is to rank a friend’s experience as a less reliable source, while a source with a commercial 
interest such as a web-based sales site might reasonably be judged less reliable still.  
 Our expectation was that both doctors and members of the public would doubt the 
reliability of a web-based sales site, and we included this in the study reported below as a 
check that participants treated the task as intended. What was not obvious, however, was how 
members of the public would evaluate the other four sources of evidence. In particular, would 
they consider the evidence from an RCT to be more trustworthy than evidence from an audit 
(both of which were described without the use of these labels), or than the experience of a 
single doctor, or of a friend with experience of the same ailment?  
 There are grounds for predicting that members of the public might not accord 
evidence from an RCT particular standing. Many studies suggest that participants in RCTs 
struggle to understand that allocation to treatment arms is at random [5;6;7;8;9]. Even when 
trial participants do understand about their own random allocation, they may provide an 
incorrect rationale such as scarcity of resources [6;8]. If they understood and accepted the 
scientific rationale for randomisation, we would not expect the very deep-seated difficulties 
consistently reported in the literature. Results consistent with this suggestion come from 
studies involving healthy participants (potential patients) who responded to written research 
scenarios [10]. In this research, participants judged that researchers would find out just as 
much about the relative effectiveness of two treatments if treatment allocation were based on 
doctors’ and patients’ joint preferences, rather than at random. Participants failed to 
understand the scientific benefits of random allocation as opposed to allocation on the basis 
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of doctors’ and patients’ preferences, despite best efforts to explain the rationale to them 
(e.g., the explanation for random allocation then recommended by UK’s Multicentre 
Research Ethics Committees). Importantly, the problem is not due simply to failure to 
understand what random allocation means: participants accurately identified random and non-
random methods of allocation to two groups [11]. Rather, participants struggled to grasp the 
rationale for making comparisons between groups of people as opposed to what works for 
each individual, and providing explanations did not reduce their difficulty.  
 People’s difficulties accepting the rationale for evaluating treatment effectiveness 
using currently preferred research designs may impact on treatment decisions in standard 
consultations. This possibility has not been explored hitherto, but an implication is that 
patients arrive at their consultation hoping to be offered treatments that may not be supported 
by clinical evidence that meets the practitioner’s standards. When discussing treatment 
options with their practitioner, there may be a clash of perspectives about which each party 
could remain unaware, and which interferes with the process of shared decision-making 
about treatments.  
 Shared decision-making is justified on the grounds that patients are more likely to be 
satisfied with their consultation and more likely to comply with agreed treatment regimes 
when they have played an active role in discussion about their condition and about treatment 
options [12;13;14]. Despite this, patients’ preference for a shared or a direct approach has 
been found to vary with the medical condition under discussion, as well as with personal 
characteristics such as social class and age [15;16]. The UK Government’s White Paper 
(2010) [17] promised to make shared decision-making ‘the norm’ on the grounds that this 
improves patients’ satisfaction, increases adherence to the chosen treatment and reduces costs 
(p. 13, p. 45). Despite the value placed on shared decision-making by policy-makers, doctors 
face challenges in taking into account patients’ preferences [18]. It has been argued that a 
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necessary condition “for evidence-based patient choice is that the patient accurately 
comprehends a clear synthesis of high-quality, balanced empirical reports about the clinical 
diagnosis, the available therapeutic options, and their inherent advantages and disadvantages 
– that is the ‘objective evidence’” (p. 123) [13]. Yet hitherto there has been no investigation, 
so far as we are aware, of the extent to which patients and practitioners agree on the relative 
reliability of different types of evidence for treatment effectiveness.  
 Of course we cannot assume that there is uniformity of view amongst patients on the 
reliability of evidence from different sources. As a check on the extent of variation amongst 
members of the public (potential patients), we included participants from 18 to 83 years of 
age and with a wide range of educational and occupational backgrounds. We predicted that 
the older participants would show relatively high trust in the view of an experienced doctor, 
because they could have been accustomed to a paternalistic style that was more common in 
years gone by [19;20;21]. Interestingly, this same prediction about trust in sources of 
evidence arises from the finding that older people prefer to rely on experts’ opinions rather 
than take an active part in decision-making [22], and in particular that they tend to prefer a 
direct rather than a shared approach to medical decision-making [16].  
 In summary, we predicted that GPs would give highest confidence ratings to a 
treatment that had proved more successful in an RCT, with declining confidence for the other 
forms of evidence in the order: audit based on many doctors’ treatment decisions, a single 
doctor’s experience, a friend’s experience, and finally, web-based sales recommendation. We 
predicted that members of the public would differentiate less clearly than GPs between these 
forms of evidence, and in particular that the older adults would have relatively high 
confidence in a doctor’s experience.   
2. Method 
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 2.1 Ethics. Ethical approval for the research was granted by Warwick University’s 
Social Science and Humanities Research Ethics Committee. The research was conducted in 
accordance with the British Psychological Society’s ethical guidelines. Participants gave 
informed written consent to participate.  
 2.2 Participants and Recruitment. General practitioners (GPs, N = 47) were recruited 
by virtue of their studying courses at a UK University Medical School. At the end of suitable 
classes, GPs were invited to stay on to complete the questionnaire. No record was kept of the 
precise number who were unable or unwilling to stay, but this was well under 20%. Of those 
who agreed to participate, 44 revealed their ages: Mage = 47.6 years, SD = 7.9. Thirty-two 
revealed their gender: 16 female and 16 male.  
Members of the public (potential patients), none of whom had occupations within the 
health services, were (i) a sample of 56 first-year psychology undergraduates who gained 
course credit for taking part, and who were allocated at random to take part in various 
ongoing research studies in the psychology department. No-one declined. Those included 
were 47 females and 6 males, 3 gender not revealed, Mage = 19.3 years, SD = 0.65, 2 age not 
revealed; (ii) a convenience sample of 50 mature adults aged 23 to 63 years, recruited 
personally by the third author from the local neighbourhood and workplaces. One person 
declined. Those included were 25 females and 25 males, Mage = 41.3 years, SD = 11.6; and 
(iii) a sample of 61 older adults aged at least 64, recruited from a UK Psychology 
Department’s panel of volunteers for research into ageing. One person declined and one 
failed to complete the questionnaire. Those included were 39 females and 19 males, 3 gender 
not revealed, Mage = 71.9 years, SD = 5.5.  
 The GPs had practised for a mean of 17.2 years, SD = 7.8. The undergraduates all had 
18+ school leaving qualifications; 82% of them had at least one science or mathematics 
subject. The mature adults had a range of qualifications: 24% had their highest qualification 
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at age 16, 18% at 18, 34% at degree level and 24% at postgraduate level. The corresponding 
percentages for the older adults were 30%, 15%, 34%, and 21%, respectively.  
 2.3 Materials and Procedure. Participants were invited to complete a questionnaire 
that asked them to imagine that they were suffering with ailments: headache, cough, 
indigestion, eczema and back pain. They read five hypothetical scenarios, each reporting the 
relative effectiveness of two treatments (A or B, C or D, P or Q, S or T, or X or Y) from 
different forms of evidence: RCT, audit, doctor’s clinical experience, friend’s experience or 
web-based sales recommendation. The order of the five scenarios, the labels for the 
treatments and which of the pair was more effective were counterbalanced between 
participants. See Table 1 for the wording for each form of evidence. The description of the 
RCT was closely based on reports of randomised controlled trials in the UK quality press 
(Guardian; Times; Daily Telegraph). As is typical in such reports, there was no quantitative 
information about the absolute or relative effectiveness of the two treatments under 
comparison. The descriptions of the other forms of evidence were matched for style and 
approximate number of words. Within these constraints, we aimed to describe each evidence 
type accurately, succinctly and in such a manner that the key differentiating features between 
the types would be grasped readily by participants. With these aims in mind we did not 
provide precise details of the subject populations, but used phrases such as ‘indigestion like 
yours’ implying relevance to the participant’s imagined complaint (see Table 1). Participants 
indicated how confident they would be that the treatment deemed more effective would work 
for them, using a scale from 1 (not at all confident) to 5 (very confident), with no wording on 
the intermediate numerical points.  
Table 1 near here 
 All participants completed the questionnaire individually, on paper, typically taking 
no more than 10 minutes. The GPs, undergraduates and the older adults were in small groups, 
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sitting well separated and in the presence of the Experimenter. The mature adults were either 
alone with the Experimenter (N = 14) or completed the questionnaire in their own time and 
returned it to the Experimenter a few days later, confirming they had not discussed their 
answers with anyone else (N = 36).  
3. Results  
 Table 2 shows the mean confidence scores shown by each participant group for each 
of the five types of evidence. Our strategy for testing the predictions was as follows. First, we 
conducted overall analyses to discover whether, as predicted, there was a significant 
interaction between participant group and evidence type, with the GPs differing from the 
other groups, particularly with respect to RCTs. We then examined each of the four 
participant groups separately to discover whether confidence scores differed for the five 
evidence types. Finally, we examined the possible influences of additional factors, namely, 
gender, GPs’ experience, and educational qualifications. 
 Table 2 near here.  
 Participants’ confidence scores were analysed using a 4x5 mixed-design ANOVA 
with a between-subjects factor of participant group (GPs, undergraduates, mature adults, 
older adults) and a within-subjects factor of evidence type (RCT, audit, doctor’s experience, 
friend’s experience, web-based sales recommendation). Here and elsewhere where there were 
departures from sphericity, Greenhouse-Geisser corrections to degrees of freedom and p 
values are reported. Main effects of participant group, F(3, 210) = 8.34, MSE = 1.50, p < 
.001, ηp2 = .11, and evidence type, F(3.3, 688.0) = 160.06, MSE = 0.76, p < .001, ηp2 = .43, 
were, as predicted, qualified by an interaction between participant group and evidence type, 
F(9.8, 688.0) = 3.16, MSE = 0.76, p < .001, ηp2 = .04. To locate the source of the interaction, 
first, we conducted a sequence of four 3 x 5 (participant group x evidence type) ANOVAs, 
each omitting one of the participant groups. The interaction between participant group and 
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evidence type appeared only when GPs were included, suggesting that the GPs differed from 
the other participant groups in their pattern of confidence in the different types of evidence. 
Second, a sequence of five 4 x 4 ANOVAs, each omitting one of the evidence types, showed 
that the interaction appeared only when RCT was included, suggesting that the participant 
groups differed in their confidence in RCT relative to the other types of evidence. Taken 
together, these findings suggest that it is the GPs’ trust in RCTs that is responsible for the 
original two-way interaction. 
 For each of the four participant groups, we conducted paired samples t-tests 
(significance level: p < .05) to test whether it showed descending order of trust in the 
evidence types: RCT, audit, doctor’s experience, friend’s experience and web-based sales 
recommendation. Our prediction was that the GPs would show this pattern of decreasing 
trust, but that the other three participant groups would differentiate less clearly between 
evidence types. Since we were testing against a predicted order, there was no need to correct 
for making the four planned comparisons. GPs showed relative trust that was closely in line 
with the predictions, although the audit evidence from many doctors was treated with no 
more confidence than the single doctor’s experience: RCT > audit; audit = doctor’s 
experience; doctor’s experience > friend’s experience; and friend’s experience > web-based 
sales recommendation: t(46) = 2.47, p = .017; t(46) = 0.59, p = .585; t(46) = 5.73, p < .001; 
and t(46) = 3.96, p < .001, respectively. Also broadly in line with the predictions, the three 
groups of members of the public differentiated less clearly between evidence types. For 
undergraduates, paired comparisons showed: RCT = audit; audit = doctor’s experience; 
doctor’s experience > friend’s experience; and friend’s experience > web-based sales 
recommendation: t(55) = -1.15, p = .253; t(55) = -1.31, p = .196; t(55) = 6.92, p < .001; and 
t(55) = 4.77, p < .001, respectively. For mature members of the public: RCT < audit; audit = 
doctor’s experience; doctor’s experience > friend’s experience; friend’s experience > web-
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based sales recommendation: t(49) = -2.91, p = .005; t(49) = 1.22, p = .227; t(49) = 3.24, p = 
.002; and t(49) = 7.41, p < .001, respectively. For the older adults: RCT = audit; audit < 
doctor’s experience; doctor’s experience > friend’s experience; friend’s experience > web-
based sales recommendation: t(60) = 1.00, p = .321; t(60) = -3.09, p = .003; t(60) = 6.52, p < 
.001; and t(60) = 5.19, p < .001, respectively. 
 Supplementary analyses. (i) There were no significant effects of gender. (ii) There 
were no significant effects of GPs’ years of experience. (iii) Concerning educational 
qualifications, the difference between the GPs’ and members of the public’s patterns of trust 
in the different sources of evidence was not due merely to GPs having a generally higher 
level of educational qualifications: we selected mature and older adults with postgraduate 
qualifications (N = 25) and compared their confidence scores against the GPs’. Independent 
samples t- tests revealed no significant differences for any of the evidence types (all ts < 1) 
except for RCT. For RCT, the GPs showed significantly higher trust than the members of the 
public with postgraduate qualifications, t(37.29) = 2.76, p < .01. 
4. Discussion and Conclusions 
4.1 Discussion 
 As expected, members of the public differed from the GPs in their relative confidence 
in the effectiveness of treatments evaluated by different sources of evidence, as shown by the 
interaction between participant group and evidence type. Furthermore, it appears to be the 
GPs who were distinctively different from the three groups of members of the public, as 
shown by the absence of interaction when the GPs were excluded from the analysis. 
Moreover, the GPs’ distinct pattern was specific to RCTs, as shown by the absence of 
interaction when RCT was excluded from the analysis. Also as expected, all four participant 
groups showed the lowest confidence in the recommendation from the web-based sales site, 
which we included as a check that participants understood the task as intended.  
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 Reassuringly, all participant groups had more confidence in a doctor’s experience 
than in a friend’s experience. They also all had more confidence in the latter than in the web-
based sales. The differences between GPs and members of the public lay in the relative 
weight given to RCT, audit and doctor’s experience. As predicted, GPs’ confidence was 
highest in evidence from the RCT, with lower confidence in the audit which, contrary to 
prediction, was given no more weight than a single doctor’s experience, although the mean 
confidence ratings are in the expected direction. All the GPs in our sample were studying 
courses in a University Medical School, and some were GP trainers, so they may have been 
atypically well versed in current views of a ‘hierarchy of trust’ that puts evidence from RCTs 
at the top [23]. 
 In contrast to the GPs, none of the groups of members of the public gave the highest 
confidence ratings to the RCT. As predicted, the older adults had more confidence in the 
single doctor’s experience than the audit of treatment outcomes from many doctors’ patients, 
which in turn was rated no differently from the RCT. The mature adults gave lower 
confidence ratings to the RCT than to the audit and the doctor’s experience, which did not 
differ from each other. The undergraduates showed no difference in their confidence ratings 
to the RCT, audit and doctor’s experience. Overall, then, there is no sign that members of the 
public judged RCTs to provide the gold standard for evidence about the effectiveness of 
treatments.  
 This result is consistent with the findings arising from trial participants and from 
healthy adults’ judgments about hypothetical trials: as mentioned in the introduction the 
scientific rationale for randomisation seems not to be readily understood, and many adults 
judge that doctors would find out just as much about the effectiveness of treatments from 
non-randomised designs [10]. Hitherto, such findings have been seen as important for 
ensuring that recruits into trials give adequately informed consent, for optimising recruitment, 
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and for understanding why some trial participants are upset and angry when they 
subsequently discover that they or their family members were randomised [8]. The research 
reported here highlights an implication that has so far been ignored, namely, the possible 
impact of failures to understand the scientific rationale for randomising on decision-making 
in standard consultations that have no research component. Unlike GPs, members of the 
public (potential patients) appear to place no particularly high value on evidence from RCTs 
as compared with clinical audit and a single doctor’s experience, and so might prefer a 
treatment whose effectiveness has not been demonstrated in a way that their GP finds 
convincing.   
 In addition to any difficulty understanding the scientific advantages of random 
allocation, the older adults in our sample showed particular trust in the experience of a doctor 
who, according to the scenario ‘has built up an impression of how well her patients do on 
each of the treatments.’ This trust in the doctor’s view is unlikely to lead to disagreements 
between patient and doctor about proposed treatment, as even if the doctor’s view were based 
on an RCT (in which the older adults had relatively low confidence), the patient can defer to 
the doctor’s view. The more important implication is for shared decision-making, in which 
older patients may be unwilling to engage [16]. The policy of making shared decision-making 
the norm might not be welcomed by older patients in particular.  
4.2 Conclusions 
 Prior to this study, it was unknown to what extent doctors and members of the public 
agreed or disagreed about what constitutes the best evidence for the effectiveness of 
treatments. It could have been, for example, that members of the public had greater 
confidence in a friend’s experience than in more objective evidence. This was not the case. 
To that extent, the findings give no cause for alarm that doctors and patients have 
fundamentally different views on what constitutes good evidence for the effectiveness of 
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treatments. Yet as far as evidence from RCTs is concerned, doctors need to be alert: while 
they may treat RCTs as the gold standard, their patients may not.  
4.3 Practice Implications 
 When decision-making about treatments includes discussion about the evidence for 
the effectiveness of treatments, doctors might check on whether they and their patient agree 
on their trust in such evidence, and the relative weight they are willing to attach to it. Older 
patients in particular might place more weight on the doctor’s personal experience than on 
RCTs, while the doctor might place more weight on evidence from RCTs than on a doctor’s 
personal experience.    
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